Imunon, Inc.
IMNN
$1.16
$0.7445179.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -34.27% | -21.61% | 66.26% | -10.04% | -- |
| Gross Profit | 34.27% | 21.61% | -66.26% | 10.04% | -- |
| SG&A Expenses | 15.29% | -20.76% | -13.26% | -6.25% | -43.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.28% | -30.52% | 27.08% | -8.42% | -11.84% |
| Operating Income | 17.28% | 30.52% | -27.08% | 8.42% | 11.84% |
| Income Before Tax | 16.78% | 34.23% | -39.37% | 13.87% | 11.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.78% | 17.00% | -39.37% | 13.87% | 11.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.78% | 17.00% | -39.37% | 13.87% | 11.84% |
| EBIT | 17.28% | 30.52% | -27.08% | 8.42% | 11.84% |
| EBITDA | 17.46% | 30.31% | -27.66% | 8.68% | 12.31% |
| EPS Basic | 46.26% | 46.26% | 9.55% | 16.29% | 22.33% |
| Normalized Basic EPS | 46.28% | 57.41% | 9.54% | 11.01% | 22.32% |
| EPS Diluted | 46.26% | 46.26% | 9.55% | 16.29% | 22.33% |
| Normalized Diluted EPS | 46.28% | 57.41% | 9.54% | 11.01% | 22.32% |
| Average Basic Shares Outstanding | 54.88% | 54.45% | 54.05% | 2.89% | 13.50% |
| Average Diluted Shares Outstanding | 54.88% | 54.45% | 54.05% | 2.89% | 13.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |